Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-05-31
2005-05-31
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S002000, C435S007200, C435S239000, C435S287100, C435S288700, C435S962000, C436S010000, C436S017000, C436S056000, C436S063000, C436S164000, C436S165000, C436S174000, C436S175000, C436S546000, C436S800000, C436S824000, C436S825000
Reexamination Certificate
active
06900023
ABSTRACT:
A method for classifying and counting leukocytes comprises the steps of: (1) adding to a hematological sample the following fluorescence-labeled antibodies labeled with fluorescent dyes which emit fluorescences distinguishable from each other; (a) a first fluorescence-labeled antibody (1st antibody) which bonds specifically to leukocytes, (b) a second fluorescence-labeled antibody (2nd antibody) which bonds to at least one kind of neutrophilic cells, and (c) a third fluorescence-labeled antibody (3rd antibody) which bonds to at least one kind of immature granulocytic cells, in order to stain leukocytic cells in the sample, and removing erythrocytes from the sample; (2) analyzing the resulting sample using a flow cytometer to measure at least one scattered light signal and three separate fluorescence signals; (3) defining a group of granulocytic cells on the basis of intensity of the scattered light and intensity of fluorescence from the 1st antibody; (4) defining neutrophilic cells in the defined group of granulocylic cells on the basis of the intensity of the fluorescence from the 1st antibody and intensity of fluorescence from the 2nd or 3rd antibody; (5) classifying the defined group of the neutrophilic cells into groups of neutrophilic cells different in degree of maturity on the basis of the intensity of the fluorescence from the 2nd antibody and the intensity of the fluorescence from the 3rd antibody, and counting the number of cells in each of the groups.
REFERENCES:
patent: 5137809 (1992-08-01), Loken et al.
patent: 5413938 (1995-05-01), Tsujino et al.
patent: 5646001 (1997-07-01), Terstappen et al.
patent: 5776709 (1998-07-01), Jackson et al.
patent: 5840502 (1998-11-01), Van Vlasselaer
patent: 0 317 156 (1889-05-01), None
Hubl et al., Toward a new reference method for the leucocyte five-part differential, Cytometry 30: 72-84 (1997).*
McCarthy et al., A simple flow cytometric procedure for the determination of surface antigens on unfixed leucocytes in whole blood, Journal of immunological Methods, 163: 155-160 (1993).*
Macey et al., Hoe should CD34 + cells br analyzed? A study of three classes of antibody and five leucocyte preparation procedur s, Journal of Immunological Methods, 204: 175-188 (1997).*
Festin et al., Multicolor flow cytometric analysis of the CD45 antigen provides improved lymphoid cell discrimination in bone marrow and tissue biopsies, Journal of Immunological Methods, 177:215-224 (1994).*
Hashimi et al., Cytofluorometric detection of chronic myelocytic leukemia supervening in a patient with chronic lymphocytic leukemia, American Journal of Medicine, 80 (2): 269-275 (1986).*
Gopinath et al., Identification og Eosinophils in Lysed Whole Blood ysuing Side Scatter and CD16 Negativity, Cytometry 30: 313-316 (1997).*
Boven, K.L., Davis, B.H.; Laboratory Hematology, vol. 3, No. 4, 1997 “Abnormal Patterns of Expression of CD16 (FcRgIII) and CD11b (CRIII) Antigens by Developing Neutrophils in the Bone Marrow of Patients with Myelodysplastic Syndrome,” pp. 292 to 298.
Hubl, M.D., Wolfgang; Andert, M.D., Sylvia; Thum, Gabriele; Ortner, Sabine; and Bayer, M.D., Peter Michael; Feb. 1997; Am. J. Clin. Patholo., vol. 107, No. 2; “Value of Neutrophil CD16 Expression for Detection of Left Shift and Acute-Phase Response,” pp. 187-196.
Fujimoto Hiroyuki
Hamaguchi Yukio
Houwen Berend
Sakata Takashi
Wang Fu-sheng
Bryan Cave LLP
Gabel Gailene R.
Le Long V.
Sysmex Corporation
LandOfFree
Method for classifying and counting leukocytes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for classifying and counting leukocytes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for classifying and counting leukocytes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3402023